Suchergebnisse - "BNT162 Vaccine"

PubPharm (3.927)

51

Effectiveness of mRNA BNT162b2 and inactivated CoronaVac vaccines against severe COVID-19 outcomes among non-hospitalised children aged 1-3 years with SARS-CoV-2 Omicron infection

enthalten in: International journal of antimicrobial agents | 2024

von Wong, C. | Lau, K. | Au, I. | +2

52

Durability of COVID-19 humoral immunity post infection and different SARS-COV-2 vaccines

enthalten in: Journal of infection and public health | 2024

von Alroqi, F. | Barhoumi, T. | Masuadi, E. | +8

53

Comparable CD8+ T-cell responses to SARS-CoV-2 vaccination in single-cell transcriptomics of recently allogeneic transplanted patients and healthy individuals

enthalten in: Journal of medical virology | 2024

von Tranter, E. | Frentsch, M. | Hütter-Krönke, M. | +11

54

mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines : Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions

enthalten in: International journal of molecular sciences | 2024

von Bakos, T. | Mészáros, T. | Kozma, G. | +11

55

SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines

enthalten in: Journal of medical virology | 2024

von Zedan, H. | Smatti, M. | Al-Sadeq, D. | +12

56

Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination

enthalten in: Virology journal | 2024

von Cheng, S. | Mok, C. | Li, J. | +16

57

Comparison of Bivalent and Monovalent mRNA Vaccine Boosters

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Wong, C. | Lau, K. | Au, I. | +2

58

Different immunological responses following immunization with two mRNA vaccines

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2024

von Nakayama, T. | Todaka, R. | Sawada, A. | +4

59

Predicting Vaccine Effectiveness for Hospitalization and Symptomatic Disease for Novel SARS-CoV-2 Variants Using Neutralizing Antibody Titers

enthalten in: Viruses | 2024

von Gardner, B. | Kilpatrick, A.

60

Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults

enthalten in: JAMA | 2024

von Lu, Y. | Matuska, K. | Nadimpalli, G. | +9

CommentIn: JAMA. 2024 Mar 19;331(11):915-917. - PMID 38502085